Volume 53, Issue 4, Pages (April 2008)

Slides:

Advertisements

Similar presentations

Volume 61, Issue 5, Pages (May 2012)

Advertisements

Volume 68, Issue 6, Pages (December 2015)

Volume 62, Issue 3, Pages (September 2012)

Volume 155, Issue 3, Pages (March 1996)

The PSA Era is not Over for Prostate Cancer

PD10-11 ANALYSIS OF THE PREDICTIVE UTILITY OF PROGNOSTIC GRADE GROUPS (PGG) FOR PREDICTING PERIOPERATIVE ONCOLOGIC OUTCOMES OF RADICAL PROSTATECTOMY.

Volume 50, Issue 1, Pages (July 2006)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 44, Issue 6, Pages (December 2003)

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

Testosterone Therapy in Men With Prostate Cancer

Volume 58, Issue 5, Pages (November 2010)

Volume 53, Issue 4, Pages (April 2008)

Volume 49, Issue 2, Pages (February 2006)

Volume 74, Issue 2, Pages (August 2018)

Volume 46, Issue 3, Pages (September 2004)

Volume 53, Issue 5, Pages (May 2008)

Volume 51, Issue 4, Pages (April 2007)

Volume 69, Issue 1, Pages (January 2016)

Volume 60, Issue 6, Pages (December 2011)

Volume 70, Issue 2, Pages (August 2016)

Prostate Cancer Epidemic in Sight?

Volume 52, Issue 4, Pages (October 2007)

Volume 72, Issue 5, Pages (November 2017)

Volume 59, Issue 2, Pages (February 2011)

Volume 63, Issue 1, Pages (January 2013)

Volume 63, Issue 4, Pages e53-e56 (April 2013)

Volume 54, Issue 4, Pages (October 2008)

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 68, Issue 3, Pages (September 2015)

Volume 67, Issue 3, Pages (March 2015)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 67, Issue 6, Pages (June 2015)

Volume 71, Issue 5, Pages (May 2017)

Luis Martínez-Piñeiro European Urology Supplements

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 53, Issue 2, Pages (February 2008)

Volume 61, Issue 5, Pages (May 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 4, Pages (April 2008)

Volume 66, Issue 2, Pages (August 2014)

Volume 58, Issue 1, Pages 1-7 (July 2010)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 65, Issue 6, Pages (June 2014)

Volume 74, Issue 2, Pages (August 2018)

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Volume 62, Issue 6, Pages (December 2012)

Volume 70, Issue 2, Pages (August 2016)

Volume 50, Issue 5, Pages (November 2006)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Volume 55, Issue 6, Pages (June 2009)

Antonio Alcaraz, Pierre Teillac European Urology Supplements

Volume 53, Issue 1, Pages (January 2008)

Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy Matthew Mossanen, Kenneth.

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Volume 74, Issue 6, Pages (December 2018)

Axel Heidenreich European Urology Supplements

Volume 53, Issue 5, Pages (May 2008)

Volume 54, Issue 2, Pages (August 2008)

Volume 54, Issue 1, Pages (July 2008)

Volume 53, Issue 2, Pages (February 2008)

Fernando P. Secin, Fernando J. Bianco, Nicholas T

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Axel Heidenreich European Urology Supplements

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 53, Issue 4, Pages 758-766 (April 2008) PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes — Results from the SEARCH Database Stephen J. Freedland, James M. Hotaling, Nicholas J. Fitzsimons, Joseph C. Presti, Christopher J. Kane, Martha K. Terris, William J. Aronson, Christopher L. Amling European Urology Volume 53, Issue 4, Pages 758-766 (April 2008) DOI: 10.1016/j.eururo.2007.08.047 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Actuarial 5-yr Kaplan-Meier estimates of biochemical recurrence rates of patients treated with radical prostatectomy within the Shared Equal Access Regional Cancer Hospital (SEARCH) database between 2000 and 2006 segregated by preoperative prostate-specific antigen value (log-rank, p<0.001). Two-way log-rank p values: < 10ng/ml vs. 10–19.9ng/ml, p<0.001; < 10ng/ml vs. ≥ 20ng/ml, p<0.001; 10–19.9ng/ml vs. ≥ 20ng/ml, p=0.52. European Urology 2008 53, 758-766DOI: (10.1016/j.eururo.2007.08.047) Copyright © 2007 European Association of Urology Terms and Conditions